Vericel Corporation Logo

Email this page: News Release

Aastrom Reports Positive 12-Month Results from the RESTORE-CLI Phase 2 Clinical Trial for Ixmyelocel-T in Patients with Critical Limb Ischemia

For security reasons, registration is required before you can use this feature.
* Indicates required field